Trials / Completed
CompletedNCT00533377
ACTiF- Assessment of Closed Tibial Fractures
A Randomized, Placebo-Controlled Study To Evaluate The Efficacy, Safety And Tolerability Of CP-533,536 In Subjects With Closed Fracture Of The Tibial Shaft
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 276 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out the good and bad effects of an investigational drug called CP-533,536 in patients with closed fracture of the tibial shaft undergoing internal fixation using reamed inter-locked IM nailing procedure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CP-533, 536 | Active study drug |
| DRUG | Placebo | Placebo vehicle |
| PROCEDURE | Standard of Care | Standard surgical procedure |
| DRUG | CP-533,536 | Active study drug |
| DRUG | CP-533,536 | Active study drug |
| DRUG | CP-533,536 | Active study drug |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2007-09-21
- Last updated
- 2012-02-17
Locations
56 sites across 11 countries: United States, Australia, Bosnia and Herzegovina, Canada, Croatia, India, Japan, Russia, South Africa, Spain, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00533377. Inclusion in this directory is not an endorsement.